Eisai
FDA grants accelerated approval for first Alzheimer’s disease treatment
June 11 by Emily UwemedimoThe FDA has approved Biogen and Eisai’s Alzheimer’s disease drug aducanumab
The Launch of Once-Daily Pill Gives New Hope for Epilepsy Patients
September 28 by Pharmaceuticals & Biotechnology EditorJapanese pharmaceutical giant Eisai has launched a new epilepsy drug in Europe following approval by the European Commission. Discovered and developed in the United Kingdom, Fycompa® (perampa...
IN PROFILE: 2011 Top 10 Players in the Japanese Pharmaceutical Market
June 29 by Pharma IQPharma IQ provides you with a quick update of the activities of the Top 10 players in the Japanese pharmaceutical market in 2011. Figures according to Forbes The World Bi...
Pharmacovigilance in Japan & China - An Interview with Edward Stewart Geary
March 28 by Edward Stewart GearyPharma IQ: Can you outline the requirements for expedited and periodic reporting in Japan? Stewart Geary: There are requirements for expedited reporting of individual ca...